GSK is cutting staff, and a lot of it, reports Derek Lowe at In the Pipeline. "I'm hearing that the smallest cuts are around 40% of the entire research staff at the various sites,"  he writes. For those who have never been through a layoff, or are new to industry, Lowe wonders how much the "grass is greener" mentality will play into departing scientists' ideas of why they were let go.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.